Innovation

Pugatch Consilium and the Council for Innovation Promotion Launch Inaugural Congressional Innovation Scorecard

Posted by:

A few weeks ago, Pugatch Consilium’s Professor Meir Pugatch and Dr David Torstensson were
in Washington D.C. to help launch the inaugural edition of the Congressional Innovation
Scorecard.


The purpose of the Congressional Innovation Scorecard is to assess and rate how the U.S.
Congress as a whole and its individual members (Senators and Representatives) through their
political, legislative and policy activities work to promote and nurture America’s goal of a strong
national IP system that drives innovation, boosts economic competitiveness, and improves lives
everywhere.


The U.S. economy is ...

Continue Reading →
0

Pugatch Consilium and the U.S. Chamber of Commerce launch the 11th edition of the International IP Index

Posted by:

Last week Pugatch Consilium’s Professor Meir Pugatch and Dr David Torstensson were in Washington D.C. to help launch the eleventh edition of the U.S. Chamber of Commerce’s International IP Index.

Since 2012 the U.S. Chamber of Commerce’s International IP Index has provided an important industry perspective on the IP standards that influence both long- and short-term business and investment decisions. The Index is a unique and continuously evolving instrument. Not only does it assess the state of the international IP environment, ...

Continue Reading →
0

Professor Meir Pugatch chairs Israeli Health Council meeting on the availability of health technologies for rare and ultra-rare diseases

Posted by:

This Wednesday, February 15 2023, Managing Director of Pugatch Consilium, Professor Meir Pugatch, will chair and moderate full-day discussion on the availability of health technologies for rare and ultra-rare diseases in Israel.

Rare and ultra-rare diseases comprise a wide range of complex conditions that are associated with chronic, progressive, degenerative and/or life-threatening symptoms that affect a relatively small portion of the population. Commercial, clinical and regulatory challenges are associated with the development of treatments for rare and ultra-rare diseases. The fundamental ...

Continue Reading →
0

Dr David Torstensson and U.S. Chamber of Commerce launch new fifth edition of the Global Rule of Law and Business Dashboard

Posted by:

Today Dr David Torstensson presented the findings of the 2021 Global Rule of Law and Business Dashboard at the U.S. Chamber of Commerce in Washington D.C.

Titled Building Blocks for Economic Recovery the Dashboard offers the business community, governments, policymakers and stakeholders across the world an innovative, empirical tool to measure and understand the particular needs of the business community within a rule of law context. What are the issues that are important to business? What is currently being measured internationally? And what ...

Continue Reading →
0

IP rights still matter!

Posted by:

Pugatch Consilium and the U.S. Chamber of Commerce launch the 9th edition of the International IP Index

Last week saw the launch of the ninth edition of the International IP Index. Since 2012 the U.S. Chamber of Commerce’s International IP Index has provided an important industry perspective on the IP standards that influence both long- and short-term business and investment decisions. The Index is a unique and continuously evolving instrument. Not only does it assess the state of the international IP ...

Continue Reading →
0

Professor Pugatch lead a discussion of Swedish life sciences stakeholders on how the EU is doing in the global life sciences innovation investment race

Posted by:

Yesterday Professor Pugatch spoke to an audience of Swedish life sciences stakeholders on the EU’s capacity to compete in the global life sciences innovation race, at an event organized in Stockholm by Bayer Sweden in collaboration with the Karolinska Institute Holding.

Professor Pugatch provided an evidence-based analysis of the EU’s performance in attracting life sciences investment as compared to the US and emerging Asian players, and reflected on the ongoing shifts in life sciences innovation capacities at the global level.

In which ...

Continue Reading →
0

Generating biopharmaceutical Competitiveness and Investment in emerging markets – Insights from the ground up with the 2019 Emerging Markets BCI survey

Posted by:

In the global competition for biopharmaceutical investment policy environments either enable or hinder an economy’s capacity to compete. Today who is winning this race and who is trailing? What aspects of individual economies’ environments are providing momentum and what is holding them back? And ultimately, how can governments improve their competitiveness and secure a larger piece of global biomedical investment?

To answer these questions we turned to biopharmaceutical country executives, who are at the forefront of understanding how different aspects of ...

Continue Reading →
0

Never stop reforming – six editions of Building the Bioeconomy has clear message to biotechnology policymakers around the world

Posted by:

This week I am having the pleasure of attending the 2019 BIO International Convention hosted in Philadelphia, Pennsylvania. The biggest global event of its kind, this international convention brings together stakeholders from across the biotechnologies. Whether it be from the health, agricultural or industrial sector, anyone who is anyone in biotech is in Philadelphia this week.

Every year I come to the Convention I am struck by the sheer growth in numbers. More participants; more international delegations; more interest in biotech. ...

Continue Reading →
0

Pugatch Consilium is releasing the sixth edition of the Building the Bioeconomy

Posted by:

Pugatch Consilium is today releasing the sixth edition of the Building the Bioeconomy, a series of papers commissioned by the Biotechnology Industry Organization. Since 2013, the series has taken the pulse of biotechnology policies in the main economies worldwide, and has shown that policy choices are key determinants of success in growing biotechnology sectors.
This year’s edition adds to the analysis eleven countries, further increasing the geographic and economic diversity of the countries sampled. Yet, the findings of the report ...

Continue Reading →
0

New Pugatch Consilium Study Shows How Countries Can Develop Biotech Industry

Posted by:

A Pugatch Consilium study released today commissioned by the Biotechnology Innovation Organization (BIO) highlights strategies, policies and best practices that have been successful in creating an environment in which biotechnology innovation can flourish around the world.

The fifth edition of the Building the Bioeconomy report shows the correlation between economies with pro-innovation policy frameworks and those achieving strong biotechnology outputs. By examining 28 different indicators ranging from public policy inputs to biotechnology outputs, the report provides a full and detailed ...

Continue Reading →
0
Page 1 of 2 12